3M™ Kerramax Care™ Super-Absorbent Dressing

3M ID B5005265101
  • Super-absorbent dressings for absorbing and retaining high levels of exudate1*
  • Sequesters and retains bacteria and MMPs2*,3* away from the wound bed, preventing the transmission risk of infection
  • Soft, conformable and foldable4
  • Easy to apply4 using either side of the dressing
 More...
View all details
View Legal Disclaimer
Specifications
Brand
Kerramax Care™
Details
  • Super-absorbent dressings for absorbing and retaining high levels of exudate1*
  • Sequesters and retains bacteria and MMPs2*,3* away from the wound bed, preventing the transmission risk of infection
  • Soft, conformable and foldable4
  • Easy to apply4 using either side of the dressing
  • Suitable for use under compression5*

3M™ Kerramax Care™ Dressings are a range of super-absorbent dressings that absorb and retain high amounts of wound exudate1*. The unique wicking layer evenly distributes fluid both horizontally and vertically throughout the dressing, utilizing the full absorption capacity. Exudate is locked away, including bacteria2* and MMPs3*, creating an optimal environment for wound healing, helping to transform patient outcomes. Its high conformability allows the dressing to be folded to suit a variety of different wounds.

Kerramax Care Dressings offer an advanced method of absorbing exudate from wounds utilising Exu-Safe™ Technology built into the dressing core. This super-absorbent core absorbs and retains moderate to high levels of fluid away from the wound bed – including bacteria2* and MMPs3* - protecting delicate wound tissue and surrounding skin whilst helping to reduce the risk of maceration, even under compression4*. The unique wicking layer draws up serous and viscous5 exudate, distributing it evenly throughout the dressing, utilising the full absorption capacity and helping to prevent bulking. Its heat-sealed border prevents exudate leakage. The dressings have a soft, non-woven material on both sides of the dressing, so either side can be placed on the wound whilst being comfortable for the patient. Soft, conformable and foldable5 Easy to apply5 using either side of the dressing Use under compression4

Documents
Large Volume Order​

Send Us a Message

Thank you for your interest in 3M. In order to help us manage and respond to your query effectively, we politely ask you to provide some key information, including your contact details. The information you provide will be used to respond to your request through email or telephone by a 3M representative or one of our authorised business partners with whom we might share your personal information consistent with the 3M privacy policy

  •  
  •  
  •  
  •  
  •  
  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Send Message

Thank you for your contacting 3M

We have received your message and are now looking into your enquiry
One of our representatives will get in touch with you by phone or email

An error occurred.


Legal Disclaimer

¹ Jackson S, Warde D. Determination of free swell absorption and fluid retention, and absorption capacity under pressure of KERRAMAX CARE™. CHC R596. Crawford Healthcare. 2017. Knutsford, UK. ² Singh G, Thomason H. Sequestration and retention of bacteria by superabsorbent dressings over time. CHC R1043 (in vitro). University of Manchester & Crawford Healthcare. 2020. Knutsford, UK. ³ Singh G, Thomason H. Sequestration of matrix metalloproteinases (MMPs) by superabsorbent wound dressings. CHC R1042 (in vitro). University of Manchester & Crawford Healthcare. 2020. Knutsford, UK. ⁴ Cotton S. The management of a chronic leg ulcer using Kerramax Care™ Super-Absorbent Dressing under compression. Poster presented at: Wounds UK; November 2015; Harrogate, UK. ⁵ Hughes M. A large-scale evaluation of managing moderate and highly exuding wounds in the community. Wounds UK. 2017;13(3):78–85. *As demonstrated in vitro